| Authors: |
Kakavand H; Melanoma Institute Australia, North Sydney, NSW, Australia.; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia., Vilain RE; Melanoma Institute Australia, North Sydney, NSW, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Wilmott JS; Melanoma Institute Australia, North Sydney, NSW, Australia.; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia., Burke H; Melanoma Institute Australia, North Sydney, NSW, Australia., Yearley JH; Merck Research Laboratories, Palo Alto, CA, USA., Thompson JF; Melanoma Institute Australia, North Sydney, NSW, Australia.; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia., Hersey P; Melanoma Institute Australia, North Sydney, NSW, Australia.; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.; Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, NSW, Australia., Long GV; Melanoma Institute Australia, North Sydney, NSW, Australia.; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia., Scolyer RA; Melanoma Institute Australia, North Sydney, NSW, Australia.; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. |
